Galapagos | Leverandørgjeld



Trade Creditors Endring Dato
AstraZeneca 22.46B 781M 2024-12
Biogen USD 424.2M 1.5M 2024-12
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
GRIFOLS EUR 852.3M 25.42M 2024-12
Hikma Pharmaceutical USD 541M 232M 2024-06
Incyte USD 197.46M 18.76M 2024-12
Merck EUR 1.5B 448M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Roche Holding 4.35B 828M 2024-12
Sanofi 7.43B 105M 2024-06
UCB 750M 1.66B 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Galapagos Leverandørgjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.